FDA NDC Directory · JSON-LD · Markdown

Cefepime

NDC 60505-6246 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA203704
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsCEFEPIME HYDROCHLORIDE (2 g/1)
Marketing started20220901
Package count1

External sources

Source: openFDA. Public-domain (CC0).